INTRINSIC EDGE CAPITAL MANAGEMENT LLC – Castle Biosciences, Inc. Transaction History
INTRINSIC EDGE CAPITAL MANAGEMENT LLC portfolio value:
$8.14M
portfolio value
INTRINSIC EDGE CAPITAL MANAGEMENT LLC quarter portfolio value change:
+18.82%
quarter
Castle Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +10.62% | 30K shares | 1.94M | $26.08 | 312.4K |
| Q2 2022 | share | Increase | +32.96% | 70K shares | -3.32M | $21.95 | 282.4K |
| Q1 2022 | share | Increase | 0.00% | 212.4K shares | 9.52M | $44.86 | 212.4K |
| Q4 2021 | share | Decrease | -100.00% | -147.89K shares | -9.83M | $43.82 | 0 |
| Q3 2021 | share | Decrease | -12.99% | -22.07K shares | -2.62M | $66.5 | 147.89K |
| Q2 2021 | share | Increase | +324.91% | 129.96K shares | 9.72M | $73.33 | 169.96K |
| Q1 2021 | share | Increase | 0.00% | 40K shares | 2.73M | $68.46 | 40K |